3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
8
Sarcoma
3
Thoracic
2
Head & Neck
2
Endocrine
2
Dermatologic
2
Other solid neoplasm
1
NET
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Neuroendocrine Tumors
110
Gastro-enteropancreatic neuroendocrine tumor
19
Carcinoma, Neuroendocrine
12
Stomach Neoplasms
10
Neoplasms
10
Breast Neoplasms
10
Pheochromocytoma
9
Pancreatic Neoplasms
9
Carcinoid Tumor
9
Prostatic Neoplasms
8
Paraganglioma
8
Neoplasm Metastasis
8
Carcinoma, Hepatocellular
8
Adenoma, Islet Cell
8
Thyroid Neoplasms
7
Gastrointestinal Neoplasms
7
Esophageal Neoplasms
7
Sarcoma
6
Lung Neoplasms
6
Colorectal Neoplasms
6
Rectal Neoplasms
5
Ovarian Neoplasms
5
Neuroblastoma
5
Melanoma
5
Liver Neoplasms
5
Colonic Neoplasms
5
Anus Neoplasms
5
Uterine Cervical Neoplasms
4
Gastrointestinal Stromal Tumors
4
Cholangiocarcinoma
4
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Esthesioneuroblastoma, Olfactory
×
NET
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled